Cristine Alves Da Costa

Dr. Cristine Alves da Costa obtained a PhD in Toxicology from the Faculty of Pharmaceutical Sciences, USP, Brazil in 1997. Actually, Dr. Alves da Costa is a research director at INSERM and drives a team at the “Institute of Pharmacology Moléculaire et Cellulaire” (IPMC-CNRS). Her research interests include neurodegenerative diseases and brain tumors. Dr. Alves da Costa is currently is editor-in chief of Parkinson’s disease and editorial board member of Oncogene, Cells and Current Neuropharmacology. She has published more than 78 articles.